Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Towards the Development of Brain Penetrant, GAT-1 Selective Radioligands

Alexandra Sowa, Xia Shao, Allen Brooks, Peter Scott and Michael Kilbourn
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1027;
Alexandra Sowa
1University of Michigan Ann Arbor MI United States
2University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xia Shao
1University of Michigan Ann Arbor MI United States
2University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allen Brooks
1University of Michigan Ann Arbor MI United States
2University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Scott
1University of Michigan Ann Arbor MI United States
2University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Kilbourn
1University of Michigan Ann Arbor MI United States
2University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1027

Objectives: PET imaging of the GABA transporter type 1 (GAT-1) is not yet possible due to a lack of appropriate radiotracers. Our previous efforts to synthesize GAT-1 selective PET radioligands were based on previously reported lipophilic nipecotic acid derivatives,1 and the presence of a free carboxylic acid group on these derivatives interfered with BBB permeability. Bioisosteres of carboxylic acids have long been used in CNS drug development. We will report the use of carboxylic acid bioisosteres to preserve selectivity while increasing BBB permeability in the development of a GAT-1 selective PET probe. Methods: Recent efforts have been focused on the radiolabeling and in vivo evaluation of both [18F]-labeled lipophilic nipecotic acid derivatives (1a,1b), and 11C-N-methylated nipecotic acid (2a) and its ethyl ester (2b). The lipophilic nipecotic acid derivatives were labeled as previously described and evaluated in both Sprague Dawley rats and non-human primates. Nipecotic acid ethyl ester was N-[11C]-methylated using [11C]-methyl triflate in DMF.2 The free N-[11C]methyl-nipecotic acid was formed by saponification of the ester with LiOH (0.5 mL, 100 °C, 5 min). Identities of radiotracers were confirmed by HPLC. The radiolabeled carboxylic acid and ethyl ester were evaluated by microPET imaging in Sprague Dawley rats. Concurrently, a tetrazole was found as the most promising in a preliminary in vitro study of commercially available bioisosteres. Following this lead, a 3-tetrazole piperidine (3) has been synthesized using published methods.3 Results: [18F]Fluorination and [11C]methylation reactions were performed manually or using an automated synthesis module. The lipophilic nipecotic acid derivative 1a was prepared in 13% radiochemical conversion (RCC) from the chloro precursor, while 2 was prepared in 24% (acid form) and 53% (ester form). MicroPET imaging showed that for each set, brain uptakes of free acids (1a,2a) were very low; whereas, measureable levels of the corresponding esters could be observed for both esters (1b,2b). Conclusions: The comparison of the simple nipecotic acid (2a) and ester (2b) with the larger lipophilic GAT-1 ligands (1a,1b) supports a conclusion that it is predominantly the free carboxylic acid function that limits BBB permeability. These results demonstrate the need for the development of carboxylic acid bioisosteres for use in these GAT-1 radioligands. Syntheses of analogs of 1a and 2a but with a tetrazole replacing the carboxylic acid (as in 3) are in progress. These syntheses will be discussed, as well as initial in vivo evaluation of new radio tracers. Acknowledgements: Research was supported by NIH grant R21NS086758. 1. G. Quandt, G. Hofner and K. T. Wanner, Bioorg Med Chem, 2013, 21, 3363-3378. 2. T. Nguyen, S.E. Snyder, and M.R. Kilbourn, Nucl Med Biol, 1998, 25, 761-768. 3. S. Harusawa, H. Yoneyama, Y. Usami and S. Komeda, Synthesis, 2013, 45, 1051-1059.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Towards the Development of Brain Penetrant, GAT-1 Selective Radioligands
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Towards the Development of Brain Penetrant, GAT-1 Selective Radioligands
Alexandra Sowa, Xia Shao, Allen Brooks, Peter Scott, Michael Kilbourn
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1027;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Towards the Development of Brain Penetrant, GAT-1 Selective Radioligands
Alexandra Sowa, Xia Shao, Allen Brooks, Peter Scott, Michael Kilbourn
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1027;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Probes for Neuroimaging Posters

  • Radiosynthesis and evaluation of a high affinity GSK3 ligand [11C]CMP
  • A Phase 0 Study for Amino Acid Imaging Using D-18F-FMT PET in Human Brains
  • Preparation of Metal-Protein Aggregate Radioligand [11C]HQ415 and Evaluation by Small Animal PET Imaging
Show more Probes for Neuroimaging Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire